Herpesvirus DNA polymerase — Drug Target

All drugs that target Herpesvirus DNA polymerase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Nucleoside analog antiviral

Marketed (1)

• Experimental: Valacyclovir treatment · University of Pittsburgh · Nucleoside analog antiviral · Infectious Disease / Virology
  Valacyclovir is a prodrug that is converted to acyclovir, which inhibits viral DNA polymerase to prevent herpesvirus replication.